Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine.

Martinez D, Slifstein M, Narendran R, Foltin RW, Broft A, Hwang DR, Perez A, Abi-Dargham A, Fischman MW, Kleber HD, Laruelle M.

Neuropsychopharmacology. 2009 Jun;34(7):1774-82. doi: 10.1038/npp.2008.235. Epub 2009 Jan 28.

2.

Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis.

Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM.

Am J Drug Alcohol Abuse. 2008;34(5):611-6. doi: 10.1080/00952990802308122.

PMID:
18821454
3.

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.

Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoya I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O'Brien CP, Ling W, Kleber H, Herman BH.

Drug Alcohol Depend. 2008 Sep 1;97(1-2):158-68. doi: 10.1016/j.drugalcdep.2008.04.002. Epub 2008 May 27.

4.

Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M.

Am J Psychiatry. 2007 Apr;164(4):622-9.

PMID:
17403976
5.

Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M.

Neuropsychopharmacology. 2004 Jun;29(6):1190-202. Erratum in: Neuropsychopharmacology. 2004 Sep;29(9):1763. Frankel, W Gordon [corrected to Frankle, W Gordon].

6.

The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.

Foltin RW, Ward AS, Collins ED, Haney M, Hart CL, Fischman MW.

Exp Clin Psychopharmacol. 2003 May;11(2):123-30.

PMID:
12755456
7.

Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.

Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2002 Dec;164(4):407-15. Epub 2002 Sep 14.

PMID:
12457271
8.

Effects of the NMDA antagonist memantine on human methamphetamine discrimination.

Hart CL, Haney M, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2002 Dec;164(4):376-84. Epub 2002 Oct 5.

PMID:
12457267
9.

Effects of oral THC maintenance on smoked marijuana self-administration.

Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW.

Drug Alcohol Depend. 2002 Aug 1;67(3):301-9.

PMID:
12127201
10.

Intravenous buprenorphine self-administration by detoxified heroin abusers.

Comer SD, Collins ED, Fischman MW.

J Pharmacol Exp Ther. 2002 Apr;301(1):266-76.

PMID:
11907183
11.

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.

Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW.

Psychopharmacology (Berl). 2002 Feb;159(4):351-60. Epub 2001 Nov 1.

12.

Effects of acute smoked marijuana on complex cognitive performance.

Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW.

Neuropsychopharmacology. 2001 Nov;25(5):757-65.

13.

Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.

Evans SM, Walsh SL, Levin FR, Foltin RW, Fischman MW, Bigelow GE.

Drug Alcohol Depend. 2001 Nov 1;64(3):271-83.

PMID:
11672942
14.

Methamphetamine self-administration by humans.

Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 Aug;157(1):75-81.

PMID:
11512046
15.

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW.

Psychopharmacology (Berl). 2001 Aug;157(1):1-10.

PMID:
11512037
16.

Effects of repeated oral methamphetamine administration in humans.

Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 Jun;155(4):397-404.

PMID:
11441429
17.

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.

Haney M, Ward AS, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 Jun;155(4):330-7.

PMID:
11441422
18.

Bupropion SR worsens mood during marijuana withdrawal in humans.

Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 May;155(2):171-9.

PMID:
11401006
19.

Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.

Comer SD, Collins ED, Fischman MW.

Psychopharmacology (Berl). 2001 Feb;154(1):28-37.

PMID:
11292003
20.

Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain.

Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D, Franceschi M, Logan J, Gatley SJ, Wong C, Ding YS, Hitzemann R, Pappas N.

Life Sci. 2000 Aug 11;67(12):1507-15.

PMID:
10983846
21.

Increased sensitivity to alprazolam in females with a paternal history of alcoholism.

Evans SM, Levin FR, Fischman MW.

Psychopharmacology (Berl). 2000 Jun;150(2):150-62.

PMID:
10907668
22.

Alternative reinforcers differentially modify cocaine self-administration by humans.

Hart CL, Haney M, Foltin RW, Fischman MW.

Behav Pharmacol. 2000 Feb;11(1):87-91.

PMID:
10821213
23.
24.

Limited sex differences in response to "binge" smoked cocaine use in humans.

Evans SM, Haney M, Fischman MW, Foltin RW.

Neuropsychopharmacology. 1999 Sep;21(3):445-54.

25.

Positron emission tomography studies of dopamine-enhancing drugs.

Fowler JS, Volkow ND, Ding YS, Wang GJ, Dewey S, Fischman MW, Foltin R, Hitzemann R.

J Clin Pharmacol. 1999 Aug;39(S1):13S-16S. Review.

PMID:
10434242
26.

Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization.

Suckow RF, Zhang MF, Collins ED, Fischman MW, Cooper TB.

J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):217-24.

PMID:
10410945
27.

Fluoxetine-maintained obese humans: effect on food intake and body weight.

Ward AS, Comer SD, Haney M, Fischman MW, Foltin RW.

Physiol Behav. 1999 Jul;66(5):815-21.

PMID:
10405110
28.

Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.

Comer SD, Collins ED, MacArthur RB, Fischman MW.

Psychopharmacology (Berl). 1999 Apr;143(4):327-38.

PMID:
10367549
29.
30.

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans.

Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1999 Mar;143(1):102-10.

PMID:
10227086
31.

Abstinence symptoms following smoked marijuana in humans.

Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1999 Feb;141(4):395-404.

PMID:
10090647
32.

Abstinence symptoms following oral THC administration to humans.

Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1999 Feb;141(4):385-94.

PMID:
10090646
33.

The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans.

Collins ED, Ward AS, McDowell DM, Foltin RW, Fischman MW.

Behav Pharmacol. 1998 Nov;9(7):587-98.

PMID:
9862084
34.

Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans.

Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW.

Behav Pharmacol. 1998 Nov;9(7):577-86.

PMID:
9862083
35.
36.

Smoked cocaine self-administration in females and voucher incentives for abstinence.

Evans SM, Levin FR, Fischman MW, Foltin RW.

J Subst Abuse. 1998;10(2):143-62.

PMID:
9854700
37.

Binge cocaine self-administration by humans: smoked cocaine.

Ward AS, Haney M, Fischman MW, Foltin RW.

Behav Pharmacol. 1997 Dec;8(8):736-44.

PMID:
9832960
38.

Choice between money and intranasal heroin in morphine-maintained humans.

Comer SD, Collins ED, Fischman MW.

Behav Pharmacol. 1997 Dec;8(8):677-90.

PMID:
9832953
39.

Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.

Evans SM, Haney M, Levin FR, Foltin RW, Fischman MW.

Neuropsychopharmacology. 1998 Dec;19(6):499-516.

40.

Effects of "binge" use of intravenous cocaine in methadone-maintained individuals.

Foltin RW, Fischman MW.

Addiction. 1998 Jun;93(6):825-36.

PMID:
9744118
41.

Effects of methysergide and loratadine on food intake, mood, and performance of humans living in a residential laboratory.

Comer SD, Haney M, Ward AS, Fischman MW, Foltin RW.

Physiol Behav. 1998 May;64(2):159-64.

PMID:
9662080
42.

Effects of pergolide on intravenous cocaine self-administration in men and women.

Haney M, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1998 May;137(1):15-24.

PMID:
9631952
43.

Effects of an alternative reinforcer on intravenous heroin self-administration by humans.

Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW.

Eur J Pharmacol. 1998 Mar 12;345(1):13-26.

PMID:
9593589
44.

Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET.

Logan J, Volkow ND, Fowler JS, Wang GJ, Fischman MW, Foltin RW, Abumrad NN, Vitkun S, Gatley SJ, Pappas N, Hitzemann R, Shea CE.

Synapse. 1997 Dec;27(4):347-56.

PMID:
9372557
45.

A laboratory model of cocaine withdrawal in humans: intravenous cocaine.

Foltin RW, Fischman MW.

Exp Clin Psychopharmacol. 1997 Nov;5(4):404-11.

PMID:
9386968
46.

Effects of caffeine withdrawal on humans living in a residential laboratory.

Comer SD, Haney M, Foltin RW, Fischman MW.

Exp Clin Psychopharmacol. 1997 Nov;5(4):399-403.

PMID:
9386967
47.

Cyproheptadine produced modest increases in total caloric intake by humans.

Comer SD, Haney M, Fischman MW, Foltin RW.

Physiol Behav. 1997 Oct;62(4):831-9.

PMID:
9284505
48.

Residual effects of repeated cocaine smoking in humans.

Foltin RW, Fischman MW.

Drug Alcohol Depend. 1997 Aug 25;47(2):117-24.

PMID:
9298333
49.

The effects of a monetary alternative on marijuana self-administration.

Ward AS, Comer SD, Haney M, Foltin RW, Fischman MW.

Behav Pharmacol. 1997 Aug;8(4):275-86.

PMID:
9832987
50.

Binge cocaine self-administration in humans: intravenous cocaine.

Ward AS, Haney M, Fischman MW, Foltin RW.

Psychopharmacology (Berl). 1997 Aug;132(4):375-81.

PMID:
9298515

Supplemental Content

Loading ...
Support Center